ACORN CAPITAL ADVISORS, LLC Q3 2025 Filing
Filed November 17, 2025
Portfolio Value
$197.0M
Holdings
20
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (20 positions)
| Stock | Value |
|---|---|
CGONCG ONCOLOGY INC | $45.6M |
URGNUROGEN PHARMA LTD | $25.1M |
PBYIPUMA BIOTECHNOLOGY INC | $21.9M |
TRVITREVI THERAPEUTICS INC | $19.6M |
TERNTERNS PHARMACEUTICALS INC | $14.8M |
CADLCANDEL THERAPEUTICS INC | $13.2M |
BCAXBICARA THERAPEUTICS | $10.2M |
OKURONKURE THERAPEUTICS INC | $7.8M |
TARAPROTARA THERAPEUTICS INC | $7.6M |
VSTMVERASTEM INC | $6.9M |
HELPCYBIN INC | $4.3M |
CRDFCARDIF ONCOLOGY INC | $4.0M |
AURAAURA BIOSCIENCES INC | $3.7M |
BCABBIOATLA INC | $3.3M |
JSPRJASPER THERAPEUTICS | $3.3M |
WHWKWHITEHAWK THERAPEUTICS INC | $2.2M |
QTTBQ32 BIO INC. | $1.6M |
ASNSUSDX4 PHARMACEUTICALS INC | $935K |
ACRVACRIVON THERAPEUTICS INC | $733K |
VYNEVYNE THERAPEUTICS INC | $199K |